Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPY4R | P50391 | 5/20 | 0.31 |
| ▸ | NPY1R | P25929 | 3/20 | 0.31 |
| ▸ | NPY2R | P49146 | 2/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL420406 | 0.88 | TRPV1 (0.41) | TRPV1MEN1KMT2ADPP7 | |
| SCHEMBL420338 | 0.87 | TRPV1 (0.43) | TRPV1ALOX15MEN1CYP1A2KMT2A | |
| SCHEMBL15061137 | 0.81 | ALOX15 (0.36) | TRPV1ALOX15MEN1CYP1A2KMT2A | |
| SCHEMBL15061139 | 0.77 | ALOX15 (0.38) | TRPV1ALOX15MEN1CYP1A2KMT2A | |
| SCHEMBL10292018 | 0.76 | DPP7 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL8214683 | 0.76 | DPP7 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL8745865 | 0.76 | DPP7 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL420402 | 0.74 | TRPV1 (0.45) | TRPV1DPP7 | |
| SCHEMBL419516 | 0.74 | TRPV1 (0.45) | TRPV1MEN1KMT2ADPP7 | |
| SCHEMBL25300066 | 0.73 | NPY4R (0.39) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120060856-A1 | Cosmetic Composition and Reshaping Method for Keratinic Fibers | HENKEL AG & CO. KGAA (DE) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120060856-A1 | Cosmetic Composition and Reshaping Method for Keratinic Fibers | H1-0, H1-3, H1-2 | TRPV1 1161/4885ALOX15 4521/4885MEN1 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.